An interventional study of Stroop task and Cold pressor test in Healthy and Acute Pain, sponsored by Copenhagen University Hospital, Hvidovre. Active, not recruiting at 1 site in Denmark. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-19.
Sponsored by Copenhagen University Hospital, Hvidovre · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Acute Pain with a site in Denmark — 3 open to participants now, 4 under way, none of them phase 3. Acute Pain · Denmark.
Among the 19 studies in Acute Pain with a site in Denmark, this one is the 11th largest by planned enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2024, is one of 7 with no phase, and was the 18th registered.
1,077 studies on the registry are indexed under Acute Pain; 168 are open to participants now.
Browse Acute Pain studies →3 of the 19 studies in Acute Pain with a site in Denmark are open now. Recruiting first, the newest first:
Odense University Hospital · Sites in Denmark
Ages 18+
Kristian Kjær Petersen · Sites in Denmark
Ages 18–45 · Healthy volunteers
Aalborg University · Sites in Denmark
Ages 18–80 · Healthy volunteers
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 103 Acute Pain studies recruiting now, 40 (39%) set no upper age limit and 50 (49%) stop at 75 or younger; 21 take children under 18; 24 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 37 is below the median of 86 across 905 interventional studies indexed under Acute Pain.
Median enrollment 50 across the 15 interventional studies, 144 across the 4 observational. Of the 15 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 19 have an industry lead sponsor. The 10 most frequent:
Copenhagen University Hospital, Hvidovre is the lead sponsor of 79 studies on the registry; 19 are open to participants now.
Copenhagen University Hospital, Hvidovre has 1 study filed under Acute Pain — fewer than ten, so there is no comparison to draw.
2 of the studies in Acute Pain with a site in Denmark that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06678217Copenhagen University Hospital, HvidovreDetection of Electrodermal Activity in Pain 1 | 2026-12-01 |
| NCT07930897Odense University HospitalPost-Discharge Pain Management Following Fractures in Adults in the Emergency Department: The POST-PAIN Study | 2027-03-22 |
Add all 2 to your calendar (.ics) → With an account.
Among the 19 studies in Acute Pain with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to investigate the association between self-reported pain and electrodermal activity and to develop an algorithm that detects pain-related changes in electrodermal activity in healthy volunteers undergoing a cold pressor test. The study is exploratory.
The main research questions are:
Can pain be detected using electrodermal activity, and do psychological variables, including stress, affect the electrodermal response to pain?
Study Design:
The study has two arms.
Methodology:
Thirty-seven healthy volunteers perform an experimental pain task while their electrodermal activity is recorded and complete questionnaires. The participants are randomized 1:1 to either the cold pressor test alone or the cold pressor test combined with a mild experimental stressor (Stroop task).
Analysis:
Discriminant analysis will be used to differentiate between mild, moderate, and severe pain levels. Secondary outcomes include assessing the influence of the mild stressor on the pain response. This study is exploratory, generating hypotheses for subsequent phases of the project.
Methods Research Design The purpose of phase 1 is to develop an algorithm to assess and predict pain using biological signals and self-reported outcome measures. For phase 1, a randomized controlled trial design will be used. Group 1 will undergo the Cold Pressor Test (CPT) only, while Group 2 will undergo the CPT in addition to the Stroop task.
Measures Subjective measures (Self-Reported) Pain. Pain intensity (interval, 0 to 10) is measured using the numerical rating scale (NRS), a commonly used tool asking patients to rate their pain intensity on a scale from 0 to 10, with 0 indicating no pain and 10 reflecting the worst possible pain.
Pain Catastrophizing. It is measured using the Pain Catastrophizing Scale (PCS). This scale is short, and consists of 13-items scored on a 5-point Likert scale from 0 (not at all) to 4 (all the time).
Patient Health Status. The Patient Health Questionnaire is commonly used to provisionally diagnose depression and grade severity of symptoms in general medical and mental health settings. The PHQ-9 is the depression module.
Objective measures Electrodermal activity. A wearable device provided by Movisens GmbH will be used to record skin conductance measured in microsiemens (μS).
Cardiac activity. Additionally, 4-channel ECG signal with Texas Instruments ADS1299 will be used to collect data for calculating the periodic repolarization period (PRD).
Interventions \& Apparatus
The Cold Pressor Test The CPT test will be used to induce tonic pain in phase 1.The CPT is a tonic pain stimulus where participants immerse their hand into 2 degrees Celcius cold water.
The Stroop task The Stroop task will be used as a mild, acute stressor.
Wearable device The EdaMove 4 device provided by Movisens GmbH consists of an EDA and activity sensor. It will be used to collect data during the entire experimental procedure including the CPT and Stroop task.
Texas Instruments ADS1299 amplifier Texas Instruments ADS1299 amplifier will be used to collect a 4-channel ECG signal to analyze the PRD during the tonic pain stimulation with the CPT.
Software Python, R and STATA will be used for statistical analyses.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants go through the cold pressor test.
Other: Cold pressor test
Participants go through the Stroop task before the cold pressor test.
Other: Stroop task · Other: Cold pressor test
The Stroop task will be used as a mild, acute stressor since it has effects on anxiety and autonomic response. In each Stroop task condition, four coloured visual stimuli will be presented on a computer screen for 3 s with 7 s inter-stimulus interval. The stimuli will be coloured words naming the colour of the ink in the nonconflict task condition (e.g. GREEN written in green ink) and a different colour in the conflict task condition (e.g. GREEN written in red ink). The participants were asked to name the colour of the stimuli. The test will be administered using the online version of PsyToolKit (Stoet, 2021).
The participant lowers their hand in icy water to induce temporary tonic pain
Pain intensity
Numerical rating scale score. Pain intensity (interval, 0 to 10) is measured using the NRS, a commonly used tool asking patients to rate their pain intensity on a scale from 0 to 10, with 0 indicating no pain and 10 reflecting the worst possible pain.
Time frame: while participants have their wrist immersed in cold water for the Cold Pressor Test, for maximum 3 minutes.
Skin conductance level
The average skin conductance value (μS) for periods of 10 seconds.
Time frame: while participants wear the device throughout testing, which lasts up to fifteen minutes.
Number of Skin Conductance Fluctuations
Peaks with minimum amplitudes of 0.02 μS and a slope rate \< 2 μS/s, in 10 second intervals.
Time frame: while participants wear the device throughout testing, which lasts up to fifteen minutes.
Cold pressor endurance time
Maximum time of immersion in cold water.
Time frame: while participants have their wrist immersed in cold water for the Cold Pressor Test
The Patient Health Questionnaire (PHQ-9)
The Patient Health Questionnaire (PHQ-9) will be used to screen participants as symptoms of depression in order to control during the statistical analysis. The PHQ-9 is the depression module, which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day), providing a 0 to 27 severity score.
Time frame: administered the day of testing
Pain Catastrophizing
It is measured using the Pain Catastrophizing Scale (PCS). This scale is short, and consists of 13-items scored on a 5-point Likert scale from 0 (not at all) to 4 (all the time), asking participants to reflect on past painful experiences, and to indicate the degree to which they experienced each of 13 thoughts or feelings when experiencing pain Higher scores indicate higher levels of pain catastrophizing and the total score range varies from 0 to 52.
Time frame: administered the day of testing
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Dec 2026, 24 months after the start.
Of 425 non-industry interventional studies with no phase under Acute Pain, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 24 months is above that.
Counting every sponsor, half of 431 studies reached it within 11 months; a quarter within 5 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Copenhagen University Hospital, Hvidovre